Skip to content

Effect of ayurvedic treatment on diabetic retinopathy

Experimental evaluation of retinoprotective activity of the polyherbal compound and adjunct effect of ayurvedic intervention and conventional standard of care in pramehaja timira w.s.r. non-proliferative diabetic retinopathy â?? A double arm exploratory trial

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/08/056373
Enrollment
40
Registered
2023-08-10
Start date
Unknown
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E113- Type 2 diabetes mellitus with ophthalmic complications

Interventions

None listed

Sponsors

All India Institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1Patients suffering from Type II DM having Mild to Moderate Non-Proliferative Diabetic Retinopathy 2Patients willing for Ayurveda treatment protocol. 3Patients having history of Diabetes mellitus more than 5 years. 4Patients of DR who have undergone modern medical management and Laser Photocoagulation therapy previously for the same but with persisting symptoms and/or signs will also be included in the study. 5Taking oral hypoglycemic drugs or insulin

Exclusion criteria

Exclusion criteria: 1History of glaucoma 2Patients with moderate to severe Cataractous changes. 3Patients having proliferative and advanced Diabetic Retinopathy changes. 4Patients with any other complications of Diabetes like nephropathy and neuropathy. 5Patient having systemic diseases like hypertension, thyroid etc.

Design outcomes

Primary

MeasureTime frame
1To assess the retino-protective activity of polyherbal compound in the selected in-vivo model in terms of its anti- angiogenic activity 2To evaluate the change in the retinal oedema & retinal haemorrhages in patients with Non-Proliferative Diabetic Retinopathy in terms of OCT and Fundus photographs.Timepoint: 80 days including 40 days follow up

Secondary

MeasureTime frame
1.Change in number & size of hard & soft exudates in terms of Fundus photographs. 2.Change in the quality of ocular health of patients of NPDR in terms of EDTRS visual acuity. Timepoint: 80 days including 40 days follow up

Countries

India

Contacts

Public ContactAkanksha Thakur

All India Institute of Medical sciences

venkyprao@yahoo.com9868971811

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026